Aims This study aimed to investigate the impact of cardiac resynchronization therapy with a
defibrillator (CRT-D) on mortality, comparing it with CRT with a pacemaker (CRT-P) …

Cardiac resynchronization therapy (CRT) using a biventricular pacing system has been an
effective therapeutic strategy in patients with symptomatic heart failure with a reduced left …

Background Current guidelines recommend considering multiple factors while deciding
between cardiac resynchronization therapy with a defibrillator (CRT-D) or a pacemaker …

Background Evidence from randomized trials is conflicting on the effects of cardiac
resynchronization therapy (CRT) by sex, and differences in access are unknown. We …

Background Cardiac contractility modulation (CCM) is an FDA-approved device-based
therapy for patients with systolic heart failure and normal QRS width who are symptomatic …

Background It remains to be determined whether patients receiving cardiac
resynchronization therapy (CRT) benefit from the addition of an implantable cardioverter …

Background: Cardiac resynchronization therapy (CRT) represents a major medical advance
in patients with heart failure with electrical dyssynchrony to improve symptoms, reduce …

Background Cardiac resynchronization therapy (CRT) is a major device therapy used to
treat patients suffering from heart failure (HF) and electrical asynchrony. It can improve HF …

Background Current guidelines did not provide recommendations on indications of an
additional implantable cardioverter‐defibrillator (ICD) to patients receiving cardiac …

Background Panoramic studies in patients with cardiac resynchronization therapy with a
defibrillator (CRT‐D) focusing on the etiology and indication are scarce. Besides, a …